Literature DB >> 14515327

Comparative analysis of remyelinating potential of focal and intravenous administration of autologous bone marrow cells into the rat demyelinated spinal cord.

Michio Inoue1, Osamu Honmou, Shinichi Oka, Kiyohiro Houkin, Kazuo Hashi, Jeffery D Kocsis.   

Abstract

The remyelinating potential of autologous bone marrow cells was studied after direct injection and following intravenous injection into rats with a demyelinated lesion in the spinal cord. Both focal and intravenous injections of acutely isolated mononuclear bone marrow cell fractions resulted in varying degrees of remyelination. Suspensions of bone marrow cells collected from the same rat were delivered at varied concentrations (10(2) to 10(5) for direct injection and 10(4) to 10(7) for i.v. injections). The lesions were examined histologically 3 weeks after transplantation. Light microscopic examination revealed remyelination in the dorsal funiculus with both injection protocols, but the extent of remyelination was proportional to the number of injected cells. To attain the same relative density of remyelination achieved by direct injection, intravenous administration of cells required delivery of substantially more cells (two orders of magnitude). However, the availability of autologous bone marrow cells in large number and the potential for systemically delivering cells to target lesion areas without neurosurgical intervention suggest the potential utility of intravenous cell delivery as a prospective therapeutic approach in demyelinating disease. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14515327      PMCID: PMC2605389          DOI: 10.1002/glia.10285

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  34 in total

1.  Targeting of marrow-derived astrocytes to the ischemic brain.

Authors:  M A Eglitis; D Dawson; K W Park; M M Mouradian
Journal:  Neuroreport       Date:  1999-04-26       Impact factor: 1.837

2.  Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex.

Authors:  E Y Snyder; C Yoon; J D Flax; J D Macklis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Bone marrow transplantation for autoimmune diseases.

Authors:  S Ikehara
Journal:  Acta Haematol       Date:  1998       Impact factor: 2.195

4.  Soluble intercelluar adhesion molecule-1, E-selectin, vascular cell adhesion molecule-1 and von Willebrand factor in stroke.

Authors:  A Blann; P Kumar; J Krupinski; C McCollum; D G Beevers; G Y Lip
Journal:  Blood Coagul Fibrinolysis       Date:  1999-07       Impact factor: 1.276

Review 5.  Stem cell homing: rolling, crawling, and nesting.

Authors:  P J Quesenberry; P S Becker
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

6.  Embryonic stem cell-derived glial precursors: a source of myelinating transplants.

Authors:  O Brüstle; K N Jones; R D Learish; K Karram; K Choudhary; O D Wiestler; I D Duncan; R D McKay
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation.

Authors:  D G Phinney; G Kopen; R L Isaacson; D J Prockop
Journal:  J Cell Biochem       Date:  1999-03-15       Impact factor: 4.429

8.  Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts.

Authors:  S A Azizi; D Stokes; B J Augelli; C DiGirolamo; D J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

9.  Muscle regeneration by bone marrow-derived myogenic progenitors.

Authors:  G Ferrari; G Cusella-De Angelis; M Coletta; E Paolucci; A Stornaiuolo; G Cossu; F Mavilio
Journal:  Science       Date:  1998-03-06       Impact factor: 47.728

10.  Role of adhesion molecules in the homing and mobilization of murine hematopoietic stem and progenitor cells.

Authors:  M Vermeulen; F Le Pesteur; M C Gagnerault; J Y Mary; F Sainteny; F Lepault
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

View more
  18 in total

Review 1.  Bone marrow stem cells and polymer hydrogels--two strategies for spinal cord injury repair.

Authors:  Eva Syková; Pavla Jendelová; Lucia Urdzíková; Petr Lesný; Ales Hejcl
Journal:  Cell Mol Neurobiol       Date:  2006-04-22       Impact factor: 5.046

2.  Comparison of transplantation of bone marrow stromal cells (BMSC) and stem cell mobilization by granulocyte colony stimulating factor after traumatic brain injury in rat.

Authors:  Mehrdad Bakhtiary; Mohsen Marzban; Mehdi Mehdizadeh; Mohammad Taghi Joghataei; Samideh Khoei; Vahid Pirhajati Mahabadi; Bahareh Laribi; Mahdi Tondar; Arash Moshkforoush
Journal:  Iran Biomed J       Date:  2010-10

3.  Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.

Authors:  T Honma; O Honmou; S Iihoshi; K Harada; K Houkin; H Hamada; J D Kocsis
Journal:  Exp Neurol       Date:  2005-06-20       Impact factor: 5.330

4.  Effects of supermagnetic iron oxide labeling on the major functional properties of human mesenchymal stem cells from multiple sclerosis patients.

Authors:  Ibrahim Kassis; Adi Vaknin-Dembinsky; Jeff Bulte; Dimitrios Karussis
Journal:  Int J Stem Cells       Date:  2010-05       Impact factor: 2.500

5.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 6.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 7.  Mesenchymal stem cell transplantation in multiple sclerosis.

Authors:  Jeffrey A Cohen
Journal:  J Neurol Sci       Date:  2013-01-04       Impact factor: 3.181

8.  Mesenchymal stem cells derived from peripheral blood protects against ischemia.

Authors:  Ryo Ukai; Osamu Honmou; Kuniaki Harada; Kiyohiro Houkin; Hirofumi Hamada; Jeffery D Kocsis
Journal:  J Neurotrauma       Date:  2007-03       Impact factor: 5.269

9.  Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.

Authors:  H Liu; O Honmou; K Harada; K Nakamura; K Houkin; H Hamada; J D Kocsis
Journal:  Brain       Date:  2006-08-10       Impact factor: 13.501

10.  70th Birthday symposium of Prof. Dr. Riederer: autologous adult stem cells in ischemic and traumatic CNS disorders.

Authors:  Johannes P J M de Munter; Erik Ch Wolters
Journal:  J Neural Transm (Vienna)       Date:  2012-07-29       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.